Manuscripts
Showing 1530 manuscripts.
Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020A.
Citation
RM Rutsein, P Samson, T Fenton, CV Fletcher, JJ Kiser, Mofenson LM, E Smith, B Graham, M Mathew, G Aldrovani, PACTG 1020A Study Team. Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020A.. Pediatric Infectious Disease Journal. 2015. 34: 162-167. PMID: 25232777Year
2015
Journal
Pediatric Infectious Disease Journal
Study
P1020A
Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study
Citation
Ingrid T Katz, Erin Leister, Deborah Kacanek, Michael D Hughes, Arlene Bardeguez, Elizabeth Livingston, Alice Stek, David E Shapiro, Ruth Tuomala. Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study. Annals of Internal Medicine. 2015. 162: 90-99. PMID: 25599347Journal
Annals of Internal Medicine
Immunodeficiency in Children Starting Antiretroviral Therapy in Low-, Middle-, and High- Income Countries.
Citation
Mary-Ann Davies, Kunjal Pate, M Koller, B Chi, K Wools-Kaloustian, V Leroy, K Chokephaibulkit, C Chimbetete, D Avila, R Hazra, S Ayaya, F Dicko, HK Trong, M Egger. Immunodeficiency in Children Starting Antiretroviral Therapy in Low-, Middle-, and High- Income Countries.. Journal of Acquired Immune Deficiency Syndromes. 2015. 68: 62-72. PMID: 25501345Year
2015
Journal
Journal of Acquired Immune Deficiency Syndromes
Pharmacokinetic Enhancers in HIV Therapeutics
Citation
KB Larson, K Wang, C Delille, I Otofokun, EP Acosta. Pharmacokinetic Enhancers in HIV Therapeutics. Clinical Pharmacokinetics. 2014. 53: 865-872. PMID: 25164142Year
2014
Journal
Clinical Pharmacokinetics
Associations of Host Genetic Variants on CD4+ Lymphocyte Count and Plasma HIV-1 RNA in Antiretroviral Naïve Children.
Citation
Qin M, Brummel S, Singh KK, Fenton T, Apector SA. Associations of Host Genetic Variants on CD4+ Lymphocyte Count and Plasma HIV-1 RNA in Antiretroviral Naïve Children.. Pediaric Infectious Disease Journal. 2014. 33: 946-952. PMID: 2797997Year
2014
Journal
Pediaric Infectious Disease Journal
Predictors of Resolution and Persistence of Renal Laboratory Abnormalities in Pediatric HIV Infection
Citation
Charles D Mitchell, Miriam C. Chernoff, George R. Seage III, Murli R Purswani, Hans M.L. Spiegel, Gaston Zilleruelo, Carolyn Abibol, Barbara Heckman, Christopher B Ponce, James M Oleske. Predictors of Resolution and Persistence of Renal Laboratory Abnormalities in Pediatric HIV Infection. Pediatric Nephrology. 2014. 30: 153-165. PMID: 25149850Year
2014
Journal
Pediatric Nephrology
Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission
Citation
Jane C Lindsey, Michael D Hughes, Avy Violari, Susan H Eshleman, Elaine J Abrams, Mutsa Bwakura-Dangarembizi, Linda Barlow-Mosha, Portia Kamthunzi, Pauline M Sambo, Mark F Cotton, Harry Moultrie, Sandhya Khadse, Werner Schimana, Raziya Bobat, Bonnie Zimmer, Elizabeth Petzold, Lynne M Mofenson, Patrick Jean-Philippe, Paul Palumbo, International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1060 Study Team. Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission. Pediaric Infectious Disease Journal. 2014. 33: 846-854. PMID: 25222305Journal
Pediaric Infectious Disease Journal
Study
P1060
Fracture Risk by HIV Infection Status in Perinatally HIV-Exposed Children
Citation
GK Siberry, H Li, D Jacobson, PACTG 219/219c. Fracture Risk by HIV Infection Status in Perinatally HIV-Exposed Children. AIDS. 2014. 28: 247-250. PMID: 22471877Year
2014
Journal
AIDS
Study
1077BF, 1077HS
HIV-1 RNA Levels and Antiretroviral Drug Resistance in Blood and Non-blood Compartments from HIV-1-Infected Men and Women Enrolled in AIDS Clinical Trials Group Study A5077.
Citation
R Kantor, D Bettendorf, RJ Bosch, M Mann, D Katzenstein, S Cu-Uvin, R D'Aquila, L Frenkel, S Fiscus, R Coombs, ACTG A5077 Study Team. HIV-1 RNA Levels and Antiretroviral Drug Resistance in Blood and Non-blood Compartments from HIV-1-Infected Men and Women Enrolled in AIDS Clinical Trials Group Study A5077.. PLoS One. 2014. 9: e93537. PMID: 24699474Year
2014
Journal
PLoS One